Literature DB >> 27362899

Targeting CDCP1 dimerization in triple-negative breast cancer.

Heather J Wright1, Alice M Police2, Olga V Razorenova1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27362899      PMCID： PMC5026807          DOI： 10.1080/15384101.2016.1204849

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  7 in total

1.  CDCP1 cleavage is necessary for homodimerization-induced migration of triple-negative breast cancer.

Authors:  H J Wright; J Arulmoli; M Motazedi; L J Nelson; F S Heinemann; L A Flanagan; O V Razorenova
Journal:  Oncogene       Date:  2016-02-15       Impact factor: 9.867

Review 2.  Roles of CUB domain-containing protein 1 signaling in cancer invasion and metastasis.

Authors:  Takamasa Uekita; Ryuichi Sakai
Journal:  Cancer Sci       Date:  2011-09-06       Impact factor: 6.716

3.  VHL loss in renal cell carcinoma leads to up-regulation of CUB domain-containing protein 1 to stimulate PKC{delta}-driven migration.

Authors:  Olga V Razorenova; Elizabeth C Finger; Renata Colavitti; Sophia B Chernikova; Alexander D Boiko; Charles K F Chan; Adam Krieg; Barbara Bedogni; Edward LaGory; Irving L Weissman; Marianne Broome-Powell; Amato J Giaccia
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-13       Impact factor: 11.205

4.  The CUB domain. A widespread module in developmentally regulated proteins.

Authors:  P Bork; G Beckmann
Journal:  J Mol Biol       Date:  1993-05-20       Impact factor: 5.469

5.  Glucocorticoids and histone deacetylase inhibitors cooperate to block the invasiveness of basal-like breast cancer cells through novel mechanisms.

Authors:  M E Law; P E Corsino; S C Jahn; B J Davis; S Chen; B Patel; K Pham; J Lu; B Sheppard; P Nørgaard; J Hong; P Higgins; J-S Kim; H Luesch; B K Law
Journal:  Oncogene       Date:  2012-04-30       Impact factor: 9.867

6.  In vivo cleaved CDCP1 promotes early tumor dissemination via complexing with activated β1 integrin and induction of FAK/PI3K/Akt motility signaling.

Authors:  B Casar; I Rimann; H Kato; S J Shattil; J P Quigley; E I Deryugina
Journal:  Oncogene       Date:  2012-12-03       Impact factor: 9.867

Review 7.  Targeted Therapies in Triple-Negative Breast Cancer.

Authors:  Frederik Marmé; Andreas Schneeweiss
Journal:  Breast Care (Basel)       Date:  2015-06-24       Impact factor: 2.860
  7 in total
  1 in total

1.  CDCP1 drives triple-negative breast cancer metastasis through reduction of lipid-droplet abundance and stimulation of fatty acid oxidation.

Authors:  Heather J Wright; Jue Hou; Binzhi Xu; Marvin Cortez; Eric O Potma; Bruce J Tromberg; Olga V Razorenova
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-24       Impact factor: 11.205
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.